DE29707005U1 - Stabilisiertes Arzneimittel enthaltend Cysteinylderivate - Google Patents

Stabilisiertes Arzneimittel enthaltend Cysteinylderivate

Info

Publication number
DE29707005U1
DE29707005U1 DE29707005U DE29707005U DE29707005U1 DE 29707005 U1 DE29707005 U1 DE 29707005U1 DE 29707005 U DE29707005 U DE 29707005U DE 29707005 U DE29707005 U DE 29707005U DE 29707005 U1 DE29707005 U1 DE 29707005U1
Authority
DE
Germany
Prior art keywords
drug containing
stabilized drug
derivatives
containing cysteinyl
cysteinyl derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE29707005U
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Deutschland GmbH
Original Assignee
Klinge Pharma GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Pharma GmbH and Co filed Critical Klinge Pharma GmbH and Co
Priority to DE29707005U priority Critical patent/DE29707005U1/de
Publication of DE29707005U1 publication Critical patent/DE29707005U1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
DE29707005U 1997-04-18 1997-04-18 Stabilisiertes Arzneimittel enthaltend Cysteinylderivate Expired - Lifetime DE29707005U1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE29707005U DE29707005U1 (de) 1997-04-18 1997-04-18 Stabilisiertes Arzneimittel enthaltend Cysteinylderivate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE29707005U DE29707005U1 (de) 1997-04-18 1997-04-18 Stabilisiertes Arzneimittel enthaltend Cysteinylderivate

Publications (1)

Publication Number Publication Date
DE29707005U1 true DE29707005U1 (de) 1997-06-26

Family

ID=8039189

Family Applications (1)

Application Number Title Priority Date Filing Date
DE29707005U Expired - Lifetime DE29707005U1 (de) 1997-04-18 1997-04-18 Stabilisiertes Arzneimittel enthaltend Cysteinylderivate

Country Status (1)

Country Link
DE (1) DE29707005U1 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047534A1 (de) * 1997-04-18 1998-10-29 Klinge Pharma Gmbh Stabilisiertes arzneimittel enthaltend cysteinylderivate
WO2000007575A2 (en) * 1998-07-31 2000-02-17 Mount Sinai Hospital Methods and compositions for increasing insulin sensitivity
EP2453743B1 (de) 2009-07-15 2017-04-12 The Board of Trustees of The Leland Stanford Junior University N-acetyl-cysteinzusammensetzungen und ihre verwendung zur verbesserung der therapeutischen wirkung von acetaminophen

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047534A1 (de) * 1997-04-18 1998-10-29 Klinge Pharma Gmbh Stabilisiertes arzneimittel enthaltend cysteinylderivate
WO2000007575A2 (en) * 1998-07-31 2000-02-17 Mount Sinai Hospital Methods and compositions for increasing insulin sensitivity
WO2000007575A3 (en) * 1998-07-31 2000-05-11 Mount Sinai Hospital Corp Methods and compositions for increasing insulin sensitivity
US6258848B1 (en) 1998-07-31 2001-07-10 Mount Sinai Hospital Methods and compositions for increasing insulin sensitivity
EP2453743B1 (de) 2009-07-15 2017-04-12 The Board of Trustees of The Leland Stanford Junior University N-acetyl-cysteinzusammensetzungen und ihre verwendung zur verbesserung der therapeutischen wirkung von acetaminophen

Similar Documents

Publication Publication Date Title
DE59712694D1 (de) Stabilisiertes arzneimittel enthaltend cysteinylderivate
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
DE69908021D1 (de) Ziprasidonhaltige Arzneimittel
DE69513671D1 (de) Arzneimittel
ATE367150T1 (de) Arzneimittel
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
FI972292A0 (fi) Administrering av diabetes
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
NO20001776D0 (no) Medikamenter
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
PT858325E (pt) Formulacao farmaceutica liofilizada estavel
ID19343A (id) Alat penghirup bubuk obat
ID24654A (id) Formulasi farmasi omeprazola
DE69713284T2 (de) Triazol-Derivate als Arzneimittel
NO996372D0 (no) Fast farmasoeytisk preparat inneholdende benzofuanderivater
DE69813602T2 (de) Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe
DE69812708D1 (de) Neue arzneimittel enthaltend uridintriphosphat
DK0868911T3 (da) Rapamycinpræparater til oral indgivelse
NO992724D0 (no) Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater
DE69926012D1 (de) Arzneizubereitungen
DE69713505T2 (de) Arzneimittel enthaltend mizolastin mit verzögerter wirkstoffabgabe
DE29707005U1 (de) Stabilisiertes Arzneimittel enthaltend Cysteinylderivate
DE69906934D1 (de) Arzneizubereitungen
ATE259233T1 (de) Lamivudin enthaltende arzneimittel
DE59805373D1 (de) Nephroprotektive Arzneimittel

Legal Events

Date Code Title Description
R207 Utility model specification

Effective date: 19970807

R150 Term of protection extended to 6 years

Effective date: 20000623

R151 Term of protection extended to 8 years

Effective date: 20030515

R152 Term of protection extended to 10 years

Effective date: 20050513

R071 Expiry of right